Coding for Ocular Tumors

Ocular tumor coding can be challenging because ocular oncology often involves evolving lesions, diagnostic uncertainty, and terminology that does not always translate cleanly into ICD-10-CM codes. Understanding how to distinguish benign, malignant, in situ, and uncertain histologic behavior neoplasms is essential for accurate coding, medical necessity, and audit defensibility.

By
Elizabeth Cifers, MBA, MSW, CHC, CPC
September 1, 2026
4 min

Retinal Physician

1

Accurate coding for ocular tumors requires distinguishing between benign, malignant, in situ, and uncertain histologic behavior neoplasms.
2

Diagnosis codes must reflect the condition documented at the time of the visit, without using 'rule-out' coding.
3

The Table of Neoplasms provides suggested ICD-10 codes, which should be verified for accuracy and specificity.
4

Common documentation deficiencies in ocular oncology include vague terminology and lack of anatomical specificity.
5

Ocular tumor documentation is often reviewed longitudinally, making repetitive or nonspecific notes a compliance risk.

Coding for Ocular Tumors

1

2

3

4

5

Original Source(s)

Coding for Ocular Tumors

Related Content

Cognitive Behavior vs Bright Light Therapy for Insomnia in Women Undergoing Chemotherapy for Breast Cancer: A

This Week’s CGT News: Bristol Myers Ends Cellares Manufacturing Agreement

New Podcast Feature: Dr. Geoffrey Young on SurgOnc Today